ADx NeuroSciences
Technologiepark 94
9000 Zwijnaarde
BE
ADx NeuroSciences
Foundation date
16/09/2011
Sector
#Biotechnology - TherapeuticsSubsector
We create tailor-made antibodies and assays to quantify unique biomarkers in a wide variety of neurodegenerative diseases and conditions such as Alzheimer’s disease, Parkinson’s disease and traumatic brain injury. Our assays enable early detection before symptoms appear, providing valuable information from the drug development phase up to clinical practice, to improve the life of patients.
Upcoming events
All events-
0106 '23
KNOWLEDGE FOR GROWTH 2023
Event by: flanders.bio -
0506 '23
BIO International Convention 2023
Event by: Biotechnology Innovation Organisation -
0604 '23
Innovation for Health 2023
Event by: Hyphen Projects
Latest news
More news-
Imec-onderzoekers leggen basis voor in vivo detectie van traag groeiende hersentumoren, met dank aan hyperspectrale camera
Friday February 3rd 2023
Read more
-
Weber joins Vivactis Group to reinforce its Market Access capabilities
Thursday February 2nd 2023
Read more
-
Mithra CDMO announces collaboration with VaRi Bioscience for the development of a long-acting product in women’s health
Thursday February 2nd 2023
Read more